151. S1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1β or Lipocalin-2
- Author
-
Andreas Weigert, Shahzad N. Syed, Michaela Jung, Bernhard Brüne, Publica, and Albi, Elisabetta
- Subjects
0301 basic medicine ,Article Subject ,government.form_of_government ,Immunology ,Transdifferentiation ,Cell Biology ,Lipocalin ,Biology ,medicine.disease ,Phenotype ,Lymphangiogenesis ,Metastasis ,03 medical and health sciences ,Lymphatic Endothelium ,030104 developmental biology ,Vascular endothelial growth factor C ,ddc:540 ,Cancer research ,government ,medicine ,lcsh:Pathology ,Macrophage ,lipids (amino acids, peptides, and proteins) ,lcsh:RB1-214 - Abstract
A pleiotropic signaling lipid, sphingosine-1-phosphate (S1P), has been implicated in various pathophysiological processes supporting tumor growth and metastasis. However, there are only a few descriptive studies suggesting a role of S1P in tumor lymphangiogenesis, which is critical for tumor growth and dissemination. Corroborating own data, the literature suggests that apoptotic tumor cell-derived S1P alters the phenotype of tumor-associated macrophages (TAMs) to gain protumor functions. However, mechanistically, the role of TAM-induced lymphangiogenesis has only been poorly described, mostly linked to the production of lymphangiogenic factors such as vascular endothelial growth factor C (VEGF-C) and VEGF-D, or transdifferentiation into lymphatic endothelial cells. Recent findings highlight a rather underappreciated role of S1P in tumor lymphangiogenesis, referring to the production of interleukin-1β(IL-1β) and lipocalin-2 (LCN2) by a tumor-promoting macrophage phenotype. In this review, we aim to provide to the readers with the current understanding of the molecular mechanism how apoptotic cell-derived S1P triggers TAMs to promote lymphangiogenesis.
- Published
- 2017
- Full Text
- View/download PDF